Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
33846 | 83 | 33.3 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CDCP1 | Author keyword | 49 | 94% | 20% | 17 |
2 | TRASK | Author keyword | 3 | 100% | 4% | 3 |
3 | SUBTRACTIVE IMMUNIZATION | Author keyword | 2 | 38% | 6% | 5 |
4 | CUB DOMAIN CONTAINING PROTEIN 1 | Author keyword | 1 | 100% | 2% | 2 |
5 | METASTASIS INVAS SIGNALING | Address | 1 | 27% | 5% | 4 |
6 | DISCOVERY ONCOL PHARMACEUT EARLY DEV PRED | Address | 1 | 50% | 1% | 1 |
7 | NEONATAL TOLERIZATION | Author keyword | 0 | 33% | 1% | 1 |
8 | CUB DOMAIN | Author keyword | 0 | 10% | 4% | 3 |
9 | HIGH ZONE TOLERANCE | Author keyword | 0 | 25% | 1% | 1 |
10 | INVEST CLIN ONCOL INCO | Address | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CDCP1 | 49 | 94% | 20% | 17 | Search CDCP1 | Search CDCP1 |
2 | TRASK | 3 | 100% | 4% | 3 | Search TRASK | Search TRASK |
3 | SUBTRACTIVE IMMUNIZATION | 2 | 38% | 6% | 5 | Search SUBTRACTIVE+IMMUNIZATION | Search SUBTRACTIVE+IMMUNIZATION |
4 | CUB DOMAIN CONTAINING PROTEIN 1 | 1 | 100% | 2% | 2 | Search CUB+DOMAIN+CONTAINING+PROTEIN+1 | Search CUB+DOMAIN+CONTAINING+PROTEIN+1 |
5 | NEONATAL TOLERIZATION | 0 | 33% | 1% | 1 | Search NEONATAL+TOLERIZATION | Search NEONATAL+TOLERIZATION |
6 | CUB DOMAIN | 0 | 10% | 4% | 3 | Search CUB+DOMAIN | Search CUB+DOMAIN |
7 | HIGH ZONE TOLERANCE | 0 | 25% | 1% | 1 | Search HIGH+ZONE+TOLERANCE | Search HIGH+ZONE+TOLERANCE |
8 | ANCHORAGE INDEPENDENCY | 0 | 20% | 1% | 1 | Search ANCHORAGE+INDEPENDENCY | Search ANCHORAGE+INDEPENDENCY |
9 | DETERGENT RESISTANT MICRODOMAIN | 0 | 20% | 1% | 1 | Search DETERGENT+RESISTANT+MICRODOMAIN | Search DETERGENT+RESISTANT+MICRODOMAIN |
10 | MT SP1 | 0 | 20% | 1% | 1 | Search MT+SP1 | Search MT+SP1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CDCP1 | 32 | 88% | 18% | 15 |
2 | SUBSTRATE TRASK | 26 | 100% | 13% | 11 |
3 | DOMAIN CONTAINING PROTEIN 1 | 22 | 58% | 30% | 25 |
4 | REGULATES TYROSINE PHOSPHORYLATION | 5 | 63% | 6% | 5 |
5 | CUB DOMAIN | 3 | 19% | 17% | 14 |
6 | SUBTRACTIVE IMMUNIZATION | 1 | 25% | 2% | 2 |
7 | FAK INHIBITOR | 0 | 20% | 1% | 1 |
8 | RECOMBINANT KRINGLE DOMAIN | 0 | 20% | 1% | 1 |
9 | VHL LOSS | 0 | 20% | 1% | 1 |
10 | IMMUNOGOLD FILTRATION ASSAY | 0 | 17% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis | 2011 | 7 | 38 | 63% |
The Cell Surface Glycoprotein CDCP1 in Cancer-Insights, Opportunities, and Challenges | 2009 | 13 | 31 | 48% |
The role of CDCP1 (CUB domain-containing protein 1) and ADAM12 (a disintegrin and metalloproteinase 12) in ovarian cancer | 2015 | 0 | 47 | 38% |
Tolerization as a tool for generating novel monoclonal antibodies | 2002 | 2 | 13 | 38% |
Relationship between gene mutation and lung cancer metastasis | 2015 | 0 | 38 | 11% |
MONOCLONAL-ANTIBODIES PRODUCED AGAINST ANTIGENIC DETERMINANTS PRESENT IN COMPLEX-MIXTURES OF PROTEINS | 1988 | 11 | 9 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METASTASIS INVAS SIGNALING | 1 | 27% | 4.8% | 4 |
2 | DISCOVERY ONCOL PHARMACEUT EARLY DEV PRED | 1 | 50% | 1.2% | 1 |
3 | INVEST CLIN ONCOL INCO | 0 | 25% | 1.2% | 1 |
4 | ONCOL DR ROSELL | 0 | 25% | 1.2% | 1 |
5 | UMR S972 | 0 | 25% | 1.2% | 1 |
6 | NORMAL PATHOL DEV MELANOCYTES | 0 | 20% | 1.2% | 1 |
7 | HEMATOL IMMUNOL ONCOL | 0 | 10% | 2.4% | 2 |
8 | ONCOGEN UNIT | 0 | 17% | 1.2% | 1 |
9 | CANC BIOL PRECIS MED PROGRAM | 0 | 13% | 1.2% | 1 |
10 | HEMATOL IMMUNOL ONCOL RHEUMATOL | 0 | 13% | 1.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192843 | LCK INHIBITOR//SRC INHIBITORS//SRC |
2 | 0.0000151399 | CYCLE OF EROSION//NEO LAMARCKIANISM//SEELEY |
3 | 0.0000117557 | MATRIPTASE//HAI 1//HEPSIN |
4 | 0.0000099372 | GRP MOL VIROL VECTOROL//BM88//CEND1 |
5 | 0.0000092972 | ENDOSIALIN//CD248//TEM1 |
6 | 0.0000091386 | PARAVEINAL MESOPHYLL//SOYBEAN VEGETATIVE STORAGE PROTEINS//IMPROVED NUTRITIONAL QUALITY |
7 | 0.0000082560 | TETRASPANIN//CD9//CD151 |
8 | 0.0000073592 | FOCAL ADHESION KINASE//FAK//PYK2 |
9 | 0.0000069329 | PCR GENE REARRANGEMENT//PH1 POSITIVE ALL//MED CLIN MOLEC BIOL |
10 | 0.0000060995 | PBK TOPK//PDZ BINDING KINASE//PBK |